Gavin Siew Wei Tan

Gavin Siew Wei Tan

Auto-generated profile, based on publicly available information

Gavin Siew Wei Tan

Singapore Eye Research Institute, Singapore National Eye Centre, Singapore

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2020 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
BTBingyao Tan
Bingyao Tan
JCJacqueline Chua
Jacqueline Chua
ELEmily Lin
Emily Lin
JCJoyce Cheng
Joyce Cheng
AGAlfred Gan
Alfred Gan
GTGavin S. Tan
Gavin S. Tan
Diabetic retinopathy (DR) is a common microvascular ocular complication of diabetes and is a leading cause of blindness in the working-age population.1,2 The population with diabetes globally is estimated to reach 366 million in 2030, with 34.6% having DR and 7% having vision-threatening DR.3,4

28 August 2025 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
YWYilan Wu
Yilan Wu
BQBo Qian
Bo Qian
TLTingyao Li
Tingyao Li
YQYiming Qin
Yiming Qin
ZGZhouyu Guan
Zhouyu Guan
BSBin Sheng
Bin Sheng

5 November 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
RMRyan Eyn Kidd Man
Ryan Eyn Kidd Man
AGAlfred Tau Liang Gan
Alfred Tau Liang Gan
EFEva K Fenwick
Eva K Fenwick
PGPreeti Gupta
Preeti Gupta
MWMark Yu Zheng Wong
Mark Yu Zheng Wong
ELEcosse Lamoureux
Ecosse Lamoureux
This study examined the associations of body mass index (BMI), waist circumference (WC), waist-hip ratio (WHR) and waist-height ratio (WHtR) with diabetic kidney disease (DKD) in a clinical sample of Asian patients with type 2 diabetes (T2DM); substantiated with a meta-analysis of the above associations. We recruited 405 patients with T2DM (mean (standard deviation (SD)) age: 58 (7.5) years; 277 (68.4%) male; 203 (50.1%) with DKD) from a tertiary care centre in Singapore. DKD was defined as urinary albumin-creatinine ratio >3.3 mg/mmoL and/or estimated glomerular filtration rate <60 mL/min/1.73 m2. All exposures were analysed continuously and categorically (World Health Organization cut-points for BMI and WC; median for WHR and WHtR) with DKD using stepwise logistic regression models adjusted for traditional risk factors. Additionally, we synthesized the pooled odds ratio of 18 studies (N = 19,755) in a meta-analysis of the above relationships in T2DM. We found that overweight and obese persons (categorized using BMI) were more likely to have DKD compared to under/normal weight individuals, while no associations were found for abdominal obesity exposures. In meta-analyses however, all obesity parameters were associated with increased odds of DKD. The discordance in our abdominal obesity findings compared to the pooled analyses warrants further validation via longitudinal cohorts.

18 February 2025 in eClinicalMedicine
Verified
Journal Article
Open access
QYQianhui Yang
Qianhui Yang
YBYong Mong Bee
Yong Mong Bee
CLCiwei Cynthia Lim
Ciwei Cynthia Lim
CSCharumathi Sabanayagam
Charumathi Sabanayagam
CCCarol Yim-Lui Cheung
Carol Yim-Lui Cheung
GTGavin Siew Wei Tan
Gavin Siew Wei Tan
Artificial Intelligence (AI) has been used to automate detection of retinal diseases from retinal images with great success, in particular for screening for diabetic retinopathy, a major complication of diabetes. Since persons with diabetes routinely receive retinal imaging to evaluate their diabetic retinopathy status, AI-based retinal imaging may have potential to be used as an opportunistic comprehensive screening for multiple systemic micro- and macro-vascular complications of diabetes. We conducted a qualitative systematic review on published literature using AI on retina images to detect systemic diabetes complications. We searched three main databases: PubMed, Google Scholar, and Web of Science (January 1, 2000, to October 1, 2024). Research that used AI to evaluate the associations between retinal images and diabetes-associated complications, or research involving diabetes patients with retinal imaging and AI systems were included. Our primary focus was on articles related to AI, retinal images, and diabetes-associated complications. We evaluated each study for the robustness of the studies by development of the AI algorithm, size and quality of the training dataset, internal validation and external testing, and the performance. Quality assessments were employed to ensure the inclusion of high-quality studies, and data extraction was conducted systematically to gather pertinent information for analysis. This study has been registered on PROSPERO under the registration ID CRD42023493512. From a total of 337 abstracts, 38 studies were included. These studies covered a range of topics related to prediction of diabetes from pre-diabetes or non-diabeticindividuals (n = 4), diabetes related systemic risk factors (n = 10), detection of microvascular complications (n = 8) and detection of macrovascular complications (n = 17). Most studies (n = 32) utilized color fundus photographs (CFP) as retinal image modality, while others employed optical coherence tomography (OCT) (n = 6). The performance of the AI systems varied, with an AUC ranging from 0.676 to 0.971 in prediction or identification of different complications. Study designs included cross-sectional and cohort studies with sample sizes ranging from 100 to over 100,000 participants. Risk of bias was evaluated by using the Newcastle–Ottawa Scale and AXIS, with most studies scoring as low to moderate risk. Our review highlights the potential for the use of AI algorithms applied to retina images, particularly CFP, to screen, predict, or diagnose the various microvascular and macrovascular complications of diabetes. However, we identified few studies with longitudinal data and a paucity of randomized control trials, reflecting a gap between the development of AI algorithms and real-world implementation and translational studies. Dr. Gavin Siew Wei TAN is supported by: 1. DYNAMO: Diabetes studY on Nephropathy And other Microvascular cOmplications II supported by 10.13039/501100001349 National Medical Research Council (MOH-001327-03): data collection, analysis, trial design 2. Prognositc significance of novel multimodal imaging markers for diabetic retinopathy: towards improving the staging for diabetic retinopathy supported by NMRC Clinician Scientist Award (CSA)–Investigator (INV) (MOH-001047-00).

9 February 2022 in British Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
JCJocelyn Cheong
Jocelyn Cheong
NLNicole-Ann Lim
Nicole-Ann Lim
RTRose Tan
Rose Tan
AGAlfred Tau Liang Gan
Alfred Tau Liang Gan
Jacqueline ChuaJacqueline Chua
Jacqueline Chua
GTGavin Tan
Gavin Tan
Purpose: To use optical coherence tomography angiography (OCTA) parameters from both the retinal and choroidal microvasculature to detect the presence and severity of diabetic retinopathy (DR).Method: This is a cross-sectional case–control study. OCTA parameters from retinal vasculature, fovea avascular zone (FAZ) and choriocapillaris were evaluated from 3×3 mm2fovea-centred scans. Areas under the receiver operating characteristic (ROC) curve were used to compare the discriminative power on the presence of diabetes mellitus (DM), the presence of DR and need for referral: group 1 (no DM vs DM no DR), group 2 (no DR vs any DR) and group 3 (non-proliferative DR (NPDR) vs proliferative DR (PDR)).Results: 35 eyes from 27 participants with no DM and 132 eyes from 75 with DM were included. DR severity was classified into three groups: no DR group (62 eyes), NPDR (51 eyes), PDR (19 eyes). All retinal vascular parameters, FAZ parameters and choriocapillaris parameters were strongly altered with DR stages (p<0.01), except for the deep plexus FAZ area (p=0.619). Choriocapillaris parameters allowed to better discriminate between no DM versus DM no DR group compared with retinal parameters (areas under the ROC curve=0.954 vs 0.821, p=0.006). A classification model including retinal and choroidal microvasculature significantly improved the discrimination between DR and no DR compared with each parameter separately (p=0.029).Conclusions: Evaluating OCTA parameters from both the retinal and choroidal microvasculature in 3×3 mm scans improves the discrimination of DM and early DR.

1 January 2025 in Visual Neuroscience
Verified
Journal Article
Open access
PDF file
DCDan Cao
Dan Cao
JYJie Yao
Jie Yao
DTDaniel Shu Wei Ting
Daniel Shu Wei Ting
GTGavin Siew Wei Tan
Gavin Siew Wei Tan
Diabetic macular edema (DME), a leading cause of vision impairment in diabetes, is primarily treated with intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections. However, variable treatment response rates often lead to persistent edema and irreversible vision loss. Accurate prediction of treatment response is therefore critical for optimizing treatment strategies and preserving visual function. This review examines the application of artificial intelligence (AI) to predict anti-VEGF treatment outcomes in DME. While optical coherence tomography (OCT) imaging has shown significant progress, the potential of optical coherence tomography angiography (OCTA) and fluorescein angiography (FA) remains under-exploited. AI holds considerable promise for enhancing predictive accuracy. Future research should focus on multimodal imaging approaches integrating structural, ischemic, and vascular information to develop more accurate and reliable predictive models for personalized DME treatment.